273 related articles for article (PubMed ID: 20176619)
1. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
[TBL] [Abstract][Full Text] [Related]
2. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
3. Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease.
Martin DP; Anantharam V; Jin H; Witte T; Houk R; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2011 Oct; 32(5):554-62. PubMed ID: 21871919
[TBL] [Abstract][Full Text] [Related]
4. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
5. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
6. Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity.
Ayrolles-Torro A; Imberdis T; Torrent J; Toupet K; Baskakov IV; Poncet-Montange G; Grégoire C; Roquet-Baneres F; Lehmann S; Rognan D; Pugnière M; Verdier JM; Perrier V
J Neurosci; 2011 Oct; 31(42):14882-92. PubMed ID: 22016521
[TBL] [Abstract][Full Text] [Related]
7. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
8. Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases.
Choi CJ; Kanthasamy A; Anantharam V; Kanthasamy AG
Neurotoxicology; 2006 Sep; 27(5):777-87. PubMed ID: 16860868
[TBL] [Abstract][Full Text] [Related]
9. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
10. Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death.
Choi CJ; Anantharam V; Saetveit NJ; Houk RS; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2007 Aug; 98(2):495-509. PubMed ID: 17483122
[TBL] [Abstract][Full Text] [Related]
11. Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation.
Kanthasamy AG; Choi C; Jin H; Harischandra DS; Anantharam V; Kanthasamy A
Toxicol Lett; 2012 Nov; 214(3):288-95. PubMed ID: 22995398
[TBL] [Abstract][Full Text] [Related]
12. PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.
Määttänen P; Taschuk R; Ross L; Marciniuk K; Bertram L; Potter A; Cashman NR; Napper S
Prion; 2013; 7(5):434-9. PubMed ID: 24105298
[TBL] [Abstract][Full Text] [Related]
13. Prion-induced and spontaneous formation of transmissible toxicity in PrP transgenic Drosophila.
Thackray AM; Di Y; Zhang C; Wolf H; Pradl L; Vorberg I; Andréoletti O; Bujdoso R
Biochem J; 2014 Oct; 463(1):31-40. PubMed ID: 25000212
[TBL] [Abstract][Full Text] [Related]
14. Quaternary Structure Changes for PrP
Eskandari-Sedighi G; Cortez LM; Yang J; Daude N; Shmeit K; Sim V; Westaway D
Mol Neurobiol; 2021 Jan; 58(1):375-390. PubMed ID: 32959170
[TBL] [Abstract][Full Text] [Related]
15. Abnormal brain iron homeostasis in human and animal prion disorders.
Singh A; Isaac AO; Luo X; Mohan ML; Cohen ML; Chen F; Kong Q; Bartz J; Singh N
PLoS Pathog; 2009 Mar; 5(3):e1000336. PubMed ID: 19283067
[TBL] [Abstract][Full Text] [Related]
16. An astrocyte cell line that differentially propagates murine prions.
Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
[TBL] [Abstract][Full Text] [Related]
17. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
[TBL] [Abstract][Full Text] [Related]
19. Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders.
Asthana A; Baksi S; Ashok A; Karmakar S; Mammadova N; Kokemuller R; Greenlee MH; Kong Q; Singh N
Sci Rep; 2017 Aug; 7(1):9600. PubMed ID: 28851903
[TBL] [Abstract][Full Text] [Related]
20. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein.
Vanni I; Iacobone F; D'Agostino C; Giovannelli M; Pirisinu L; Altmeppen HC; Castilla J; Torres JM; Agrimi U; Nonno R
J Biol Chem; 2023 Feb; 299(2):102823. PubMed ID: 36565989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
